<DOC>
	<DOCNO>NCT01566526</DOCNO>
	<brief_summary>The purpose study use retrospective data evaluate efficacy , safety re-injection interval OZURDEX速 treatment macular oedema due retinal vein occlusion ( RVO ) patient receive OZURDEX速 part Belgium Medical Needs Program .</brief_summary>
	<brief_title>Retrospective Data Collection Study Patients Receiving Two More OZURDEX速 Injections Macular Oedema Secondary Retinal Vein Occlusion</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Retinal Vein Occlusion</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Macular oedema least one eye due branch retinal vein occlusion ( BRVO ) central retinal vein occlusion ( CRVO ) Received least two OZURDEX速 injection study eye part Belgium Medical Needs Program</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>